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Mutational analysis of CYP2C8 in hypertensive patients using denaturing high 
performance liquid chromatography. 
 
Abstract 
What is known and Objective: CYP2C8 is involved in the cytochrome P450 (CYP) 
epoxygenase pathway. Arachidonic acid metabolites such as epoxyeicosatrienenoic acids and 
hydroxyeicosatetrenoic acids, produced may have a role in hypertension. We aimed to 
develop a medium through-put method for screening samples of known and new mutations of 
CYP2C8 using denaturing high performance liquid chromatography (DHPLC). Methods: 
DNA samples from 200 subjects (hypertensive patients and healthy controls) were screened 
for SNPs in CYP2C8 using DHPLC. Genotypes and allelic frequencies of CYP2C8 between 
the healthy controls and patients with hypertension were compared. Results and Discussions: 
Six variants were detected and two were new; T deletion at 5063 and substitution of C to T at 
33468 in exon 8. Differences in variant frequencies were detected between the controls and 
hypertensive patients. The controls have significantly higher prevalence of C35322C 
compared to the patients. The functional significance of the SNP at 35322 requires further 
study. Having homozygous C35322C could be a protective factor for hypertension. What is 
new and Conclusion: Denaturing high performance liquid chromatography is useful for 
population screening to identify new and existing SNPs. A higher frequency of the C35322T 
SNP was observed among hypertensive patients than control subjects. This potentially 
important observation requires confirmation and the clinical significance assessed. 
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